查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542512

全球重組蛋白製造服務市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Recombinant Proteins Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

全球重組蛋白製造服務市場需求預計將從 2023 年的 27.6 億美元達到 2032 年近 76 億美元的市場規模，2024-2032 年研究期間複合年成長率為 11.89%。

重組蛋白製造服務是指由生物技術和合約製造組織（CMO）提供的用於生產各種用途的重組蛋白的流程和設施。重組蛋白是由基因工程生物體（通常是細菌、酵母、哺乳動物細胞，甚至植物）產生的，以表達特定的目的蛋白。這些蛋白質用於各個領域，包括製藥、生物技術、研究、診斷和工業應用。

市場動態

由於幾個關鍵因素，重組蛋白製造服務市場正在經歷成長。對單株抗體和疫苗等生物藥物的需求推動了生物製藥產業的擴張，這是主要驅動力。生物藥物擴大用於治療各種疾病，因此需要生產這些服務所提供的重組蛋白。生命科學和生物技術的研發活動、基因工程的進步以及合約製造的外包趨勢進一步刺激了需求。慢性病盛行率的上升、COVID-19 強調的大流行防範的必要性以及蛋白質表現和純化技術的持續技術進步都有助於市場的成長。法規核准，尤其是生物製藥領域的法規核准，確保了對可靠且合規的製造服務的需求。新興市場和服務提供者提供的客製化選項也發揮了作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球重組蛋白製造服務市場的每個細分市場進行了包容性評估。重組蛋白製造服務產業的成長和趨勢為本研究提供了整體方法。

市場區隔

重組蛋白製造服務市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品和服務範圍

  • 產物（細胞激素及生長因子（干擾素（IFN）、白血球介素（IL）等）、抗體、免疫檢查點蛋白、病毒抗原、酵素（激酶、代謝酵素等）、重組調節蛋白、荷爾蒙等）
  • 製作服務

按應用範圍

  • 藥物發現與開發
  • 治療學（生物製品、疫苗、細胞和基因療法、其他）
  • 研究
  • 其他

按最終用戶範圍

  • 製藥和生物技術公司
  • 學術及研究機構
  • 診斷實驗室
  • 其他

按宿主細胞範圍

  • 哺乳動物系統
  • 昆蟲細胞
  • 酵母和真菌
  • 細菌細胞
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲重組蛋白製造服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。重組蛋白製造服務市場的主要參與者包括 Abcam Plc、Sino Biological Inc.、R&D Systems Inc.、GenScript、Bio-Rad Laboratories Inc.、Merck KGaA、Thermo Fisher Scientific、Proteintech Group Inc.、Enzo Life Sciences Inc.。 、Abnova Corp.、RayBiotech Life Inc.、Stemcell Technologies Inc.。新產品發布以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：重組蛋白製造服務 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務範圍分類的市場吸引力分析
    • 按應用範圍分類的市場吸引力分析
    • 按最終用戶範圍分類的市場吸引力分析
    • 按宿主細胞範圍進行的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球重組蛋白製造服務市場分析：依產品與服務範圍

  • 按產品和服務範圍分類的概述
  • 歷史和預測數據
  • 按產品和服務範圍分析
  • 產物（細胞激素及生長因子（干擾素（IFN）、白血球介素（IL）等）、抗體、免疫檢查點蛋白、病毒抗原、酵素（激酶、代謝酵素等）、重組調節蛋白、荷爾蒙等）
  • 製作服務

第 6 章：全球重組蛋白製造服務市場分析：依應用範圍

  • 按應用範圍概述
  • 歷史和預測數據
  • 按應用範圍分析
  • 藥物發現與開發
  • 治療學（生物製品、疫苗、細胞和基因療法、其他）
  • 研究
  • 其他

第 7 章：全球重組蛋白製造服務市場分析：依最終用戶範圍

  • 按最終用戶範圍分類的概述
  • 歷史和預測數據
  • 按最終用戶範圍分析
  • 製藥和生物技術公司
  • 學術及研究機構
  • 診斷實驗室
  • 其他

第 8 章：全球重組蛋白市場分析：依宿主細胞範圍

  • 按宿主細胞範圍概述
  • 歷史和預測數據
  • 按宿主細胞範圍進行分析
  • 哺乳動物系統
  • 昆蟲細胞
  • 酵母和真菌
  • 細菌細胞
  • 其他

第 9 章：全球重組蛋白製造服務市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：重組蛋白製造服務公司的競爭格局

  • 重組蛋白市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abcam Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sino Biological Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • R&D Systems Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GenScript
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Proteintech Group Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Enzo Life Sciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abnova Corp.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • RayBiotech Life Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Stemcell Technologies Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112112237

The global demand for Recombinant Proteins Manufacturing Services Market is presumed to reach the market size of nearly USD 7.6 Billion by 2032 from USD 2.76 Billion in 2023 with a CAGR of 11.89% under the study period 2024-2032.

Recombinant protein manufacturing services refer to the processes and facilities offered by biotechnology and contract manufacturing organizations (CMOs) to produce recombinant proteins for various purposes. Recombinant proteins are produced by genetically engineering organisms, typically bacteria, yeast, mammalian cells, or even plants, to express specific proteins of interest. These proteins are used in various fields, including pharmaceuticals, biotechnology, research, diagnostics, and industrial applications.

MARKET DYNAMICS

The recombinant proteins manufacturing services market is experiencing growth due to several key factors. The expansion of the biopharmaceutical industry, driven by the demand for biologic drugs like monoclonal antibodies and vaccines, is a primary driver. Biologic drugs are increasingly used in treating various diseases, necessitating the production of recombinant proteins, which these services provide. Research and development activities in life sciences and biotechnology, advancements in genetic engineering, and the outsourcing trend in contract manufacturing further boost demand. The rising prevalence of chronic diseases, the imperative for pandemic preparedness highlighted by COVID-19, and ongoing technological advancements in protein expression and purification techniques contribute to the market's growth. Regulatory approvals, especially in the biopharmaceutical sector, ensure the demand for reliable and compliant manufacturing services. Emerging markets and the customization options service providers offer also play a role.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Recombinant Proteins Manufacturing Services. The growth and trends of Recombinant Proteins Manufacturing Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Recombinant Proteins Manufacturing Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services Scope

  • Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others)
  • Production Services

By Application Scope

  • Drug Discovery & Development
  • Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others)
  • Research
  • Others

By End-user Scope

  • Pharma & Biotechnology Companies
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Others

By Host Cell Scope

  • Mammalian Systems
  • Insect Cells
  • Yeast & Fungi
  • Bacterial Cells
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Proteins Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Proteins Manufacturing Services market include Abcam Plc, Sino Biological Inc., R&D Systems Inc., GenScript, Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific, Proteintech Group Inc., Enzo Life Sciences Inc., Abnova Corp., RayBiotech Life Inc., Stemcell Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. RECOMBINANT PROTEINS MANUFACTURING SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services Scope
    • 3.7.2 Market Attractiveness Analysis By Application Scope
    • 3.7.3 Market Attractiveness Analysis By End-user Scope
    • 3.7.4 Market Attractiveness Analysis By Host Cell Scope
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY PRODUCT & SERVICES SCOPE

  • 5.1. Overview By Product & Services Scope
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product & Services Scope
  • 5.4. Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others) Historic and Forecast Sales By Regions
  • 5.5. Production Services Historic and Forecast Sales By Regions

6. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY APPLICATION SCOPE

  • 6.1. Overview By Application Scope
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application Scope
  • 6.4. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 6.5. Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others) Historic and Forecast Sales By Regions
  • 6.6. Research Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY END-USER SCOPE

  • 7.1. Overview By End-user Scope
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-user Scope
  • 7.4. Pharma & Biotechnology Companies Historic and Forecast Sales By Regions
  • 7.5. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 7.6. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL RECOMBINANT PROTEIN MARKET ANALYSIS BY HOST CELL SCOPE

  • 8.1. Overview By Host Cell Scope
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Host Cell Scope
  • 8.4. Mammalian Systems Historic and Forecast Sales By Regions
  • 8.5. Insect Cells Historic and Forecast Sales By Regions
  • 8.6. Yeast & Fungi Historic and Forecast Sales By Regions
  • 8.7. Bacterial Cells Historic and Forecast Sales By Regions
  • 8.8. Others Historic and Forecast Sales By Regions

9. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE RECOMBINANT PROTEINS MANUFACTURING SERVICES COMPANIES

  • 10.1. Recombinant Protein Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Abcam Plc
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Sino Biological Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. R&D Systems Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. GenScript
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Bio-Rad Laboratories Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Merck KGaA
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Thermo Fisher Scientific
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Proteintech Group Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Enzo Life Sciences Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Abnova Corp.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. RayBiotech Life Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Stemcell Technologies Inc
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product & Services Scope (USD MN)
  • Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others) Market Sales By Geography (USD MN)
  • Production Services Market Sales By Geography (USD MN)
  • Analysis By Application Scope (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others) Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user Scope (USD MN)
  • Pharma & Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Host Cell Scope (USD MN)
  • Mammalian Systems Market Sales By Geography (USD MN)
  • Insect Cells Market Sales By Geography (USD MN)
  • Yeast & Fungi Market Sales By Geography (USD MN)
  • Bacterial Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Recombinant Proteins Manufacturing Services Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Recombinant Proteins Manufacturing Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Recombinant Proteins Manufacturing Services Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product & Services Scope
  • Market Attractiveness Analysis By Application Scope
  • Market Attractiveness Analysis By End-user Scope
  • Market Attractiveness Analysis By Host Cell Scope
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product & Services Scope (USD MN)
  • Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others) Market Sales By Geography (USD MN)
  • Production Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Application Scope (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others) Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user Scope (USD MN)
  • Pharma & Biotechnology Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Host Cell Scope (USD MN)
  • Mammalian Systems Market Sales By Geography (USD MN)
  • Insect Cells Market Sales By Geography (USD MN)
  • Yeast & Fungi Market Sales By Geography (USD MN)
  • Bacterial Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.